Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions
EXCLI Journal · 04.01.2023 · 22 · 53-66
DOI: 10.17179/excli2022-5482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 04.01.2023. Verfasst von Habib Yaribeygi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a class of newly introduced antidiabetic drugs with potent hypoglycemic effects. Recent evidence suggests that these drugs have extraglycemic impacts and are therefore able to provide additional benefits beyond glucose lowering. Mitochondrial dysfunction is a central facet of many disorders that negatively impacts many tissues and organs, especially in the setting of diabetes. Therefore, it would be hugely beneficial if an antidiabetic drug could also provide mitochondrial benefits to improve cellular function and reduce the risk of diabetic complications. In this review, we have surveyed the literature for possible mitochondrial benefits of SGLT2is and we discuss the possible mechanisms involved.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
- Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Research Department, Royal College of Surgeons in Ireland Bahrain, Adliya, 15503, Bahrain.
- Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Zitieren
APA
Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2023). Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions. EXCLI Journal, 22, 53-66. https://doi.org/10.17179/excli2022-5482
Vancouver
Yaribeygi H, Maleki M, Butler AE, Jamialahmadi T, Sahebkar A. Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions. EXCLI Journal. 2023;22:53-66. doi:10.17179/excli2022-5482
BibTeX
@article{Yaribeygi2023,
author = {Yaribeygi, Habib and Maleki, Mina and Butler, Alexandra E and Jamialahmadi, Tannaz and Sahebkar, Amirhossein},
title = {Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions},
journal = {EXCLI Journal},
year = {2023},
volume = {22},
pages = {53--66},
doi = {10.17179/excli2022-5482}
}
EUVIMED